دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
2022 heatwaves: a failure to proactively manage the risks
doi : 10.1016/S0140-6736(22)01480-5
Volume 400, Issue 10350, 6–12 August 2022, Page 407
Breast radiotherapy for ductal carcinoma in situ: could less be more?
Charlotte EColesaSanjoyChatterjeebReshmaJagsicAnna MKirbyd
ESG should be judged on its own merits
Vitor OttoboniBrunaldiabChristineStiercd
Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
Christopher EBrightlingaRachael AEvansa
From food price crisis to an equitable food system
CorinnaHawkesaRamyaAmbikapathibKimAnastasioucJessicaBrockaLucianaCastronuovodNaomiFalloneHazelMalapitfAssumptaNdumigFolakeSamuelhMaryseUmugwanezaiMilkah NWanjohijChristinaZorbask
Health workers as agents of change and curators of knowledge
NigelCrispabDanPoulteracdSamGnanapragasamadCharlotteBeardmoreeAlistairFittfSheilaHollinsabJoLenaghangJoleneSkordishBernieRibeiroabMaryWatkinsab
Tulio de Oliveira: collaborating to boost science in Africa
UdaniSamarasekera
A reckoning on how we live with painHaider Warraich, The Song of Our Scars: The Untold Story of Pain, Basic Books (2022), p. 320, US$30·00, ISBN: 9781541675308
Ashley MMcMullenab
Tobacco control: the FCTC provides the route to the finish line
DeborahArnottaKylieLindorffbAndrewGoddardc
WHO must live up to its values and include data on Palestinians
Harry SShannona
Troubling assumptions behind GBD 2019 on the health risks of red meat
Vanessa L ZGordon-DseaguaMartin JWisemanaKateAllenaJudyButtrissbChristineWilliamsb
Challenges en route to polio eradication
T JacobJohnaDhanyaDharmapalanb
COVID-19 and microbiome diversity in sub-Saharan Africa
WimVan DammeaRichardWamaicYibeltalAssefadLaurensLiesenborghsbDieudonnéMumbae
COVID-19 and microbiome diversity in sub-Saharan Africa – Author's reply
Reed J DSorensenaCOVID-19 Forecasting Team
Funding to treat malnutrition: a need for greater transparency
SteveCollinsa
Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3–07/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study
ProfBoon HChuaMBBSabEmma KLinkDPhilcdIan HKunklerMBBChireTimothy JWhelanBMBChfgA HelenWestenbergMDhGuentherGruberMDiGuyBryantMBChBjVerityAhernMBBSklKashPurohitFRCRmnPeter HGrahamMBBSaoMohamedAkraMBCHBpqOrlaMcArdleMDrsPeterO'BrienMBBStuJennifer AHarveyMBBSvwCarineKirkoveMDxyJohn HMaduroMDzIan DCampbellMBChBaaabGeoff PDelaneyMDaac…Ivo AOlivottoMDaj
Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial
ProfBarham KAbu DayyehMDaFatehBazerbachiMDcEric JVargasMDaReem ZSharaihaMDdProfChristopher CThompsonMDeBradley CThaemertMDfAndre FTeixeiraMDgChristopher GChapmanMDhProfVivekKumbhariMDiMichael BUjikiMDjJeanetteAhrensPhDkCourtneyDayMSb
Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study
Aranka VBalleringMScaSander K Rvan ZonPhDbTim Colde HartmanPhDdProfJudith G MRosmalenPhDacLifelines Corona Research Initiativeâ€
Immune tolerance induction through haematopoietic chimerism after kidney donation
NimaNassiriMDabErikLumMDdMonica DMeadMDcAnn CRaldowMDeNeilKogutMDabJeffrey LVealeMDab
International law reform for One Health notifications
Colin JCarlsonPhDabAlexandra LPhelanSJDac
